BioMarin Pharmaceutical Inc. (BMRN) Presents 15 Abstracts From Basic Research To Clinical Trials At Lysosomal Disease Network's 10th Annual World Symposium™
2/13/2014 9:30:43 AM
SAN RAFAEL, Calif., Feb. 13, 2014 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today 15 data presentations at the Lysosomal Disease Network's 10th Annual WORLDSymposium™ from February 11-13 in San Diego, California.
Help employers find you! Check out all the jobs and post your resume.
comments powered by